Entellus Medical

Investor Relations

Webcast ImageWebcast
Q2 2017 Entellus Medical, Inc. Earnings Conference Call (Live)
08/03/17 at 4:30 p.m. ET
Q2 2017 Entellus Medical, Inc. Earnings Conference Call
Thursday, August 3, 2017 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
We are a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of patients in the physician office setting or operating room who are suffering from chronic sinusitis. Our XprESS family of products is used by ear, nose and throat, or ENT, physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses.
Stock Information
ENTL (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) - 0.71 (4.00%)
Data as of 07/21/17 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
Stock chart for: ENTL.O.  Currently trading at $17.03 with a 52 week high of $22.63 and a 52 week low of $11.47.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Recent NewsMore >>
07/20/17Entellus Medical to Report Second Quarter 2017 Financial Results August 3, 2017
07/07/17Entellus Medical Announces Definitive Agreement to Acquire Spirox
06/01/17Entellus Medical to Present at the William Blair Growth Stock Conference
05/22/17The Centers for Medicare & Medicaid Services (CMS) Establishes Coding and Payment for Eustachian Tube Balloon Dilation
Upcoming EventsMore >>
08/03/17 4:30 p.m. ET
Q2 2017 Entellus Medical, Inc. Earnings Conference Call